ephedrine has been researched along with Disease Exacerbation in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Béhin, A; Eymard, B; Fardeau, M; Fournier, E; Hantaï, D; Laforêt, P; Nicole, S; Richard, P; Romero, N; Servais, L; Sternberg, D; Stojkovic, T | 1 |
| Allen, D; Arunachalam, R; Beeson, D; Burke, G; Hammans, S | 1 |
| Aquilonius, SM; Asser, T; Bergquist, J; Haldre, S; Nyholm, D; Sikk, K; Taba, P; Zjablov, G | 1 |
1 review(s) available for ephedrine and Disease Exacerbation
| Article | Year |
|---|---|
[Congenital myasthenic syndromes: difficulties in the diagnosis, course and prognosis, and therapy--The French National Congenital Myasthenic Syndrome Network experience].
Topics: Adolescent; Adult; Central Nervous System Stimulants; Child; Delayed Diagnosis; Diagnostic Errors; Disease Progression; Ephedrine; Female; France; Humans; Information Centers; Male; Middle Aged; Myasthenic Syndromes, Congenital; Pregnancy; Prognosis; Young Adult | 2013 |
2 other study(ies) available for ephedrine and Disease Exacerbation
| Article | Year |
|---|---|
A treatable muscle disease.
Topics: Age Distribution; Aged; Disease Progression; Ephedrine; Extremities; Female; Gait Disorders, Neurologic; Genetic Predisposition to Disease; Horner Syndrome; Humans; Muscle Proteins; Muscle Weakness; Muscle, Skeletal; Muscular Diseases; Myasthenic Syndromes, Congenital; Neuromuscular Junction | 2009 |
Irreversible motor impairment in young addicts--ephedrone, manganism or both?
Topics: Adult; Brain; Central Nervous System Stimulants; Disability Evaluation; Disease Progression; Dyskinesia, Drug-Induced; Ephedrine; Humans; Male; Manganese Poisoning; Mass Spectrometry; Neuropsychological Tests; Parkinsonian Disorders; Potassium Permanganate; Propiophenones; Substance-Related Disorders; Sweden | 2007 |